Specialist Medical Review Council - Notification of intention to carry out a review concerning “chemically acquired brain injury caused by mefloquine, tafenoquine or primaquine”

Overview

The Veterans' Entitlements Act 1986, enacted by the Australian Parliament, aims to address issues related to the entitlements of veterans and their dependants. This legislation was introduced to fill gaps in the provision of adequate benefits and support for individuals who have served in the Australian Defence Force and their families. The Specialist Medical Review Council, established under the Act, is tasked with reviewing decisions made by the Repatriation Medical Authority regarding Statements of Principles, which are statements outlining the medical conditions that the Commonwealth recognises as having been acquired or aggravated by military service. In this instance, the Council has been asked to review the decision not to determine Statements of Principles in respect of chemically acquired brain injury caused by certain medications. This review process provides an opportunity for eligible persons and organisations to submit written comments, ensuring their views are considered in the Council's deliberations.

Scope and Application

The Specialist Medical Review Council under the Veterans’ Entitlements Act 1986 has been mandated to review the decision of the Repatriation Medical Authority (RMA) regarding the determination of Statements of Principles for "Chemically acquired brain injury caused by mefloquine, tafenoquine or primaquine." This review is triggered by applications made under section 196Y of the Act and will encompass all information previously considered by the RMA. The notice of this review is intended for eligible persons and organisations, including the Repatriation Commission, Military Rehabilitation and Compensation Commission, individuals eligible for pensions or compensation claims under the Act, and organisations representing veterans or military personnel, to ensure they are aware of the review and have the opportunity to submit written submissions by 9 February 2018. The Council will convene its first meeting post this date, with further details about the hearing of oral submissions to be communicated to relevant parties. Submissions should be directed to the Council Secretariat in Brisbane, Queensland, with contact information available on the Council's website.

Key Provisions

The main operative sections of this notification pertain to the review of a decision by the Repatriation Medical Authority (RMA) concerning “chemically acquired brain injury caused by mefloquine, tafenoquine or primaquine.” Under section 196Y of the Veterans’ Entitlements Act 1986 (the Act), the Specialist Medical Review Council (the Council) is mandated to review the RMA's decision not to determine Statements of Principles on this matter. The Council, under section 196ZB, notifies its intention to carry out this review of all the information available to the RMA when it made its decision (section 196W). This notification ensures that specific eligible persons and organisations, including the Repatriation Commission, the Military Rehabilitation and Compensation Commission, and eligible claimants, are aware of the review and have the opportunity to submit written submissions by 9 February 2018. The obligations imposed by this Act require eligible persons and organisations to be notified of the review and to have the opportunity to make written submissions to the Council. The eligible entities include the Repatriation Commission, the Military Rehabilitation and Compensation Commission, individuals eligible to make pension or compensation claims, and organisations representing veterans and their dependants. These submissions must be received by the Council by the specified date and must be lodged with the Council Secretariat at the provided address or via their website. The Council will subsequently hold its first meeting for this review after the submission deadline and will inform the requesting parties and those submitting written statements about the date, time, and location of any oral submissions hearings. The Act outlines specific consequences for non-compliance with its provisions. While the notification does not explicitly detail offences or penalties, it is understood that failure to submit written submissions by the specified date may result in forfeiture of the right to present evidence or arguments during the review process. This could potentially impact the outcome of the review if relevant and timely submissions are not provided. The Council’s proceedings and any subsequent decisions or findings will be based on the information and submissions received in accordance with the Act’s requirements.